Clearside Biomedical Announces Completion of Patient Enrollment in First of Two Phase 3 Clinical Trials of CLS-TA in Retinal Vein Occlusion

World News: . []

ALPHARETTA Ga June 13 2018 GLOBE NEWSWIRE -- Clearside Biomedical Inc NASDAQCLSD a biopharmaceutical company dedicated to developing treatments that restore and preserve vision for people with serious eye diseases today announced comp letion ...

More news and information about Clearside Biomedical, Inc.

Published By:

Globe Newswire: 21:30 GMT Wednesday 13th June 2018

Published: .

Search for other references to "clearside" on SPi News


Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2018. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Ground Floor Offices, Little Keep Gate, Barrack Road, Dorchester, Dorset DT1 1AH
Registered in England and Wales number 0751938.
 
Privacy Policy | Terms and Conditions | Contact Us